Skip to content

Processa Pharmaceuticals, Inc.: filings

Every Processa Pharmaceuticals, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 54 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-14fiscal Q2 202629810001493152-26-038334
10-Q2026-05-07fiscal Q1 202629590001493152-26-021721
10-K2026-03-18fiscal FY 202530620001493152-26-011204
10-Q2025-11-06fiscal Q3 202528790001493152-25-021069
10-Q2025-08-07fiscal Q2 202527740001493152-25-011685
10-Q2025-05-08fiscal Q1 202528560001641172-25-009252
10-K2025-03-20fiscal FY 202432650001641172-25-000070
10-Q2024-10-30fiscal Q3 202429880001493152-24-043058
10-Q2024-08-13fiscal Q2 202429870001493152-24-031622
10-Q2024-05-10fiscal Q1 202428590001493152-24-018648
10-K2024-03-29fiscal FY 202334620001493152-24-011976
10-Q2023-11-13fiscal Q3 202332830001493152-23-040472
10-Q2023-08-10fiscal Q2 202330820001493152-23-027551
10-Q2023-05-15fiscal Q1 202328540001493152-23-017001
10-K2023-03-30fiscal FY 202234600001493152-23-009730
10-Q2022-11-08fiscal Q3 202231840001493152-22-030942
10-Q2022-08-11fiscal Q2 202232790001493152-22-022063
10-Q2022-05-12fiscal Q1 202233620001493152-22-013040
10-K2022-03-30fiscal FY 202138730001493152-22-008156
10-Q2021-11-12fiscal Q3 202134880001493152-21-027929
10-Q2021-08-12fiscal Q2 202134820001493152-21-019495
10-Q2021-05-13fiscal Q1 202134680001493152-21-011311
10-K2021-03-25fiscal FY 202038750001493152-21-006807
10-Q2020-11-12fiscal Q3 202034970001493152-20-021083
10-Q2020-08-05fiscal Q2 202034890001493152-20-014712
10-Q2020-05-15fiscal Q1 202035710001493152-20-009002
10-K2020-03-06fiscal FY 201939770001493152-20-003534
10-Q2019-11-14fiscal Q3 201937970001493152-19-017267
10-Q2019-08-14fiscal Q2 201937920001493152-19-012368
10-Q2019-05-14fiscal Q1 201931640001493152-19-007021
10-K/A2019-04-08fiscal FY 201832580001493152-19-004990
10-K2019-03-28fiscal FY 201832580001493152-19-004137
10-Q2018-11-14fiscal Q3 201834770001493152-18-015821
10-Q2018-08-14fiscal Q2 201834750001493152-18-011912
10-Q2018-05-21fiscal Q1 201832570001493152-18-007514
10-K2018-04-16fiscal FY 201732790001493152-18-005248
10-Q2017-11-20fiscal Q3 201727620001393905-17-000369
10-Q2017-10-04fiscal Q2 201726610001393905-17-000302
10-Q2017-10-04fiscal Q1 201726450001393905-17-000299
10-K2017-09-25fiscal FY 201635630001393905-17-000290
10-Q2017-09-08fiscal Q3 201634790001393905-17-000272
10-Q2017-08-30fiscal Q2 201634770001393905-17-000269
10-Q2017-08-07fiscal Q1 201634610001393905-17-000223
10-K2017-06-19fiscal FY 201537740001393905-17-000190
10-Q2015-12-01fiscal Q3 2015381010001393905-15-000641
10-Q2015-08-19fiscal Q2 2015371000001393905-15-000427
10-Q2015-05-15fiscal Q1 201537750001393905-15-000259
10-K2015-04-14fiscal FY 201438760001393905-15-000193
10-Q2014-11-13fiscal Q3 201436960001393905-14-000606
10-Q2014-08-19fiscal Q2 201436960001393905-14-000488
10-Q2014-05-14fiscal Q1 201435900001393905-14-000288
10-K2014-03-27fiscal FY 201335890001393905-14-000131
10-Q2013-11-08fiscal Q3 2013361120001393905-13-000601
10-Q/A2013-09-06fiscal Q2 2013361110001393905-13-000498

Inspect the source

Entity
Processa Pharmaceuticals, Inc. / CIK 0001533743
Captured
2026-09-20T09:16:31.348Z
SEC response SHA-256
5f3216d9024f2a7fc94b315f5bf243c7efb048273a6be394a2f74186d7af2a31

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001533743.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))